arrow
R

Ronald P. Taylor

University of Virginia School of Medicine
H指数:52
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells

通过靶向共价沉积在淋巴瘤细胞上的补体C3片段增强CD20单克隆抗体疗法

BLOOD
IF23.1
2025-01-072
PRE
First dose infusion reaction during anti-CD20 monoclonal antibody therapy in chronic lymphocytic leukemia associates with high IP-10 levels amid cytokine release syndrome
2023-05-010
OA
Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome

补体因子B的突变引起旁路补体途径的大量液相失调,可导致非典型溶血性尿毒症综合征

2020-11-0113
OAAI
Multifaceted mechanism of action of DuoHexaBody-CD37 involves both complement- and Fc gamma receptor-mediated cytotoxicity in pre-clinical B-cell lymphoma models
2020-08-150
PRE
DuoHexaBody-CD37(R), a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies
2020-04-2847
OAAI
'Stealth' corporate innovation: an emerging threat for therapeutic drug development (vol 20, pg 1409, 2019)
2019-10-111
OAAI
'Stealth' corporate innovation: an emerging threat for therapeutic drug development
2019-09-2711
OAAI
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering

CD20和CD37抗体通过Fc介导的聚集协同激活补体

2019-02-2146
OAAI